Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of hypothalamic kisspeptin expression.

[1]  P. Limonta,et al.  GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. , 2016, Human reproduction update.

[2]  D. Belsham,et al.  Divergent Regulation of ER and Kiss Genes by 17β-Estradiol in Hypothalamic ARC Versus AVPV Models. , 2016, Molecular endocrinology.

[3]  A. Tamas,et al.  Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signalling Exerts Chondrogenesis Promoting and Protecting Effects: Implication of Calcineurin as a Downstream Target , 2014, PloS one.

[4]  S. Scuderi,et al.  PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways. , 2014, Experimental cell research.

[5]  J. Zawilska,et al.  PACAP38 and PACAP6-38 Exert Cytotoxic Activity Against Human Retinoblastoma Y79 Cells , 2014, Journal of Molecular Neuroscience.

[6]  H. Kanasaki,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) increases expression of the gonadotropin-releasing hormone (GnRH) receptor in GnRH-producing GT1-7 cells overexpressing PACAP type I receptor. , 2013, General and comparative endocrinology.

[7]  H. Kanasaki,et al.  Possible involvement of PACAP and PACAP type 1 receptor in GnRH-induced FSH β-subunit gene expression , 2011, Regulatory Peptides.

[8]  D. Belsham,et al.  The generation of an array of clonal, immortalized cell models from the rat hypothalamus: analysis of melatonin effects on kisspeptin and gonadotropin-inhibitory hormone neurons , 2009, Neuroscience.

[9]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery , 2009, Pharmacological Reviews.

[10]  W. Colledge,et al.  Distribution of Kisspeptin Neurones in the Adult Female Mouse Brain , 2009, Journal of neuroendocrinology.

[11]  A. Tamas,et al.  Agonistic Behavior of PACAP6-38 on Sensory Nerve Terminals and Cytotrophoblast Cells , 2008, Journal of Molecular Neuroscience.

[12]  T. Harada,et al.  Cyclic Adenosine 3′,5′Monophosphate/Protein Kinase A and Mitogen-Activated Protein Kinase 3/1 Pathways Are Involved in Adenylate Cyclase-Activating Polypeptide 1-Induced Common Alpha-Glycoprotein Subunit Gene (Cga) Expression in Mouse Pituitary Gonadotroph LbetaT2 Cells , 2007, Biology of reproduction.

[13]  H. Vaudry,et al.  VIP and PACAP stimulate TSH release from the bullfrog pituitary , 2007, Peptides.

[14]  S. Lightman,et al.  Differential Role of Corticotrophin‐Releasing Factor Receptor Types 1 and 2 in Stress‐Induced Suppression of Pulsatile Luteinising Hormone Secretion in the Female Rat , 2006, Journal of neuroendocrinology.

[15]  R. Steiner,et al.  Regulation of Kiss1 gene expression in the brain of the female mouse. , 2005, Endocrinology.

[16]  Juan F Medrano,et al.  Real-time PCR for mRNA quantitation. , 2005, BioTechniques.

[17]  S A Bustin,et al.  Quantitative real-time RT-PCR--a perspective. , 2005, Journal of molecular endocrinology.

[18]  K. O’Byrne,et al.  The Influence of 17β-oestradiol on Corticotrophin-releasing Hormone Induced Suppression of Luteinising Hormone Pulses and the Role of CRH in Hypoglycaemic Stress-induced Suppression of Pulsatile LH Secretion in the Female Rat , 2004, Stress.

[19]  S. O’Rahilly,et al.  The GPR54 Gene as a Regulator of Puberty , 2003 .

[20]  E. Génin,et al.  Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Arimura,et al.  The role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels , 2003, Journal of Molecular Neuroscience.

[22]  A. Arimura,et al.  Neonatal PACAP administration in rats delays puberty through the influence of the LHRH neuronal system , 2002, Regulatory Peptides.

[23]  P. Wise,et al.  Neurotensin gene expression increases during proestrus in the rostral medial preoptic nucleus: potential for direct communication with gonadotropin-releasing hormone neurons. , 2001, Endocrinology.

[24]  C. Ha,et al.  Central administration of an antisense oligodeoxynucleotide against type I pituitary adenylate cyclase-activating polypeptide receptor suppresses synthetic activities of LHRH-LH axis during the pubertal process. , 2000, Brain research. Molecular brain research.

[25]  C. McArdle,et al.  Pituitary Adenylate Cyclase‐Activating Peptide and Vasoactive Intestinal Peptide Receptor Expression in Immortalized LHRH Neurons , 1997, Journal of neuroendocrinology.

[26]  W. Rostène,et al.  Neurotensin and Neuroendocrine Regulation , 1997, Frontiers in Neuroendocrinology.

[27]  V. Grinevich,et al.  Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain. , 1996, Brain research. Molecular brain research.

[28]  S. T. Anderson,et al.  Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion. , 1996, Endocrinology.

[29]  S. Parsadaniantz,et al.  Activation of the hypothalamo‐anterior pituitary corticotropin‐releasing hormone, adrenocorticotropin hormone and β‐endorphin systems during the estradiol 17β‐induced plasma LH surge in the ovariectomized monkey , 1995, Journal of neuroscience research.

[30]  K. Imai,et al.  Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides. , 1995, Immunopharmacology.

[31]  S. Winters,et al.  Effects of pituitary adenylate cyclase-activating polypeptide on gonadotropin secretion and subunit messenger ribonucleic acids in perifused rat pituitary cells. , 1994, Endocrinology.

[32]  P. de Neef,et al.  Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. , 1992, European journal of biochemistry.

[33]  H. Gowing,et al.  Effects of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, on pituitary hormone release in rats. , 1992, The Journal of endocrinology.

[34]  Y. Osuga,et al.  In vivo effect of pituitary adenylate cyclase activating polypeptide 38 (PACAP 38) on the secretion of luteinizing hormone (LH) in male rats. , 1992, Endocrinologia japonica.

[35]  W. Chin,et al.  Molecular biology of the pituitary gonadotropins. , 1990, Endocrine reviews.

[36]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[37]  M. Miller,et al.  Estrogen induces neurotensin/neuromedin N messenger ribonucleic acid in a preoptic nucleus essential for the preovulatory surge of luteinizing hormone in the rat. , 1989, Endocrinology.

[38]  T. Akema,et al.  Effects of preoptic microinjection of neurotensin on luteinizing hormone secretion in unanesthetized ovariectomized rats with or without estrogen priming. , 1987, Neuroendocrinology.

[39]  C. Ferris,et al.  Stimulation of luteinizing hormone release after stereotaxic microinjection of neurotensin into the medial preoptic area of rats. , 1984, Neuroendocrinology.

[40]  R. Carraway,et al.  Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. , 1976, The Journal of biological chemistry.

[41]  R. Carraway,et al.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. , 1973, The Journal of biological chemistry.

[42]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide , 2003, Endocrine Updates.

[43]  W. Crowley,et al.  The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. , 1985, Recent progress in hormone research.